CERSSMALL

Cerus Corporation

HealthcareMedical - Devices
$2.59
$0.00(+0.00%)
52W$1.15
$3.15
Updated May 7, 12:00 AM
RSI71
RS Rating89/99
Beta2.13
Volatility76%
F-Score5/9
Mkt Cap$519M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Cerus Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 89), indicating clear outperformance against the broad market. Earnings growth of 76% provides fundamental context to the price action. However, price is extended 29% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
89
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
2.13
vs S&P 500
HIGH BETA
52W Position
72%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.01
50 SMA > 100 SMA$2.14
100 SMA > 150 SMA$1.97
150 SMA > 200 SMA$1.81

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.11+22.89%ABOVE
50 SMA$2.01+29.13%ABOVE
100 SMA$2.14+21.14%ABOVE
150 SMA$1.97+31.56%ABOVE
200 SMA$1.81+43.32%ABOVE

Price Performance

1D+0.0%
1W+34.9%
1M+40.0%
3M+17.7%
6M+83.7%
YTD+31.5%
1Y+107.2%
3Y+5.4%
52-Week Trading Range72% from low
$2.59
52W Low$1.15
52W High$3.15

Technical Indicators

RSI (14)OVERBOUGHT
70.6
305070
VCP ScoreCOOL
1/10
Base depth: 59.1%

Risk Profile

Beta
2.13
52W Vol
76%
ATR
$0.17
Max DD (1Y)
-38%

Volume Analysis

Today
2.08M
50D Avg
2.15M
Vol Ratio
0.97x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+4%
$-0.03
Q3'25+99%
$-0.00
Q4'25+16%
$-0.01
Q1'26+76%
$-0.01
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+19.67%
5 Years:+17.53%
3 Years:+8.35%
TTM:+16.97%

Compounded Profit Growth

10 Years:+17.77%
5 Years:
3 Years:
TTM:+49.61%

Stock Price CAGR

10 Years:-7.27%
5 Years:-15.35%
3 Years:+5.43%
1 Year:+107.20%

Return on Equity

10Y Avg:-71.4%
5Y Avg:-47.6%
3Y Avg:-41.7%
Last Year:-15.2%

Key Metrics

Market Cap$519M
Gross Margin53.5%
Net Margin-7.6%
Piotroski F-Score5/9

Frequently Asked Questions

Is CERS in an uptrend right now?

CERS has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is CERS overbought or oversold?

CERS's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is CERS outperforming the market?

CERS has a Relative Strength (RS) Rating of 89 out of 99. Yes, CERS is a market leader, outperforming 89% of all stocks over the past 12 months.

Where is CERS in its 52-week range?

CERS is trading at $2.59, which is 82% of its 52-week high ($3.15) and 72% above its 52-week low ($1.15).

How volatile is CERS?

CERS has a Beta of 2.13 and 52-week volatility of 76%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.